Jan Törnell
chairman
management
Neurovive Pharmaceutical
Sweden
Biography
Education: MD and PhD in physiology, University of Gothenburg. Other assignments: Editor-in-Chief for Drug Discovery Today –Disease Models and adjunct Professor at the Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg. Jan is also chairman of the Board at LIDDS AB, Glactone Pharma AB and Glactone Pharma Development AB and Director of the Board at Stayble AB and Diaprost AB, CEO at Oncorena AB and Innoext AB and partner of P.U.L.S. AB.
Research Interest
Glactone Pharma
